Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study

Michael Fendrich, Jessica Becker, Jennifer Hernandez-Meier, Michael Fendrich, Jessica Becker, Jennifer Hernandez-Meier

Abstract

Background: Drug overdose (OD) is the leading cause of accidental death in the United States and most of these deaths involve opioids. Despite research linking opioid abuse to mental illness, and evidence suggesting a large portion of opioid OD deaths are suicides, OD prevention strategies scarcely take into account mental health risk factors.

Methods: We examined a sample of heroin or other opioid users enrolled in an intervention study to determine the prevalence of overdose, the prevalence of suicide attempts in overdose, and whether those with higher levels of psychiatric symptomatology would be more likely to experience a recent OD compared to other opioid users. By performing bivariate analyses and multivariate logistic regression models that controlled for poly drug use, criminal justice status, age, race, gender, and education, we evaluated the association of severe depression, severe anxiety, posttraumatic stress disorder (PTSD) and, psychosis and past three-month OD.

Results: Just over 12% (45/368) of recent opioid users reported a recent overdose. Four of these recent overdose victims reported that the overdose was a suicide attempt. Multiple logistic regression analysis revealed that severe depression (odds ratio 2.46; 95% CI: 1.24, 4.89), PTSD (odds ratio: 2.77; 95% CI: 1.37-5.60) and psychosis (odds ratio 2.39; 95% CI: 1.10-5.15) were significantly associated with elevated odds for OD.

Conclusions: Findings suggest systematic mental health symptom screening and connection to mental health treatment for opioid users-especially those identified with OD-may be critical for OD prevention.

© 2019 The Authors.

Figures

Fig. 1
Fig. 1
Sample participation flowchart. 1PWUHO = people who use heroin or other opioids.

References

    1. American Society of Addiction Medicine Opioid addiction 2016 facts & figures. 2016. Available at.
    1. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology. 1988;56(6):893–897.
    1. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence. 2008;94(1):38–47.
    1. Binswanger I.A., Blatchford P.J., Mueller S.R., Stern M.F. Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Annals of Internal Medicine. 2013;159(9):592–600.
    1. Braden J.B., Sullivan M.D., Ray G.T., Saunders K., Merrill J., Silverberg M.J.…Von Korff M. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. General Hospital Psychiatry. 2009;31(6):564–570.
    1. Butler S.F., Fernandez K., Benoit C., Budman S.H., Jamison R.N. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R) The Journal of Pain: Official Journal of the American Pain Society. 2008;9(4):360–372.
    1. CDC Suicide: Facts at a glance. 2015. Retrieved from.
    1. CDC Understanding the epidemic. 2018. Retrieved from.
    1. Center for Behavioral Health Statistics and Quality . Substance Abuse and Mental Health Services Administration; Rockville, MD: 2014. 2013 National Survey on Drug Use and Health: Summary of national findings.
    1. Center for Behavioral Health Statistics and Quality . Substance Abuse and Mental Health Services Administration; Rockville, MD: 2016. 2015 National Survey on Drug Use and Health: Detailed tables.
    1. Cicero T.J., Ellis M.S. Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter? Drug and Alcohol Dependence. 2017;173:S4–S10.
    1. Coffin P.O., Galea S., Ahern J., Leon A.C., Vlahov D., Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction. 2003;98(6):739–747.
    1. Darke S., Hall W. Heroin overdose: Research and evidence-based intervention. Journal of Urban Health. 2003;80(2):189–200.
    1. Edlund M.J., Sullivan M., Steffick D., Harris K.M., Wells K.B. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Medicine. 2007;8(8):647–656.
    1. Faul M., Lurie P., Kinsman J.M., Dailey M.W., Crabaugh C., Sasser S.M. Multiple naloxone administrations among emergency medical service providers is increasing. Prehospital Emergency Care. 2017;21(4):411–419.
    1. Fendrich M., Becker J. Prior prescription opioid misuse in a cohort of heroin users in a treatment study. Addictive Behaviors Reports. 2018;8:8–10.
    1. Foley M., Schwab-Reese L. Associations of state-level rates of depression and fatal opioid overdose in the United States, 2011–2015. Social Psychiatriy and Psychiatric Epidemiology. 2019;54(1):131–134.
    1. Howe C.Q., Sullivan M.D. The missing “P” in pain management: How the current opioid epidemic highlights the need for psychiatric services in chronic pain care. General Hospital Psychiatry. 2014;36(1):99–104.
    1. Idiculla T.B., Eisen S.V. The BASIS-24 behavior and symptom identification scale. Integrating Science and Practice. 2012;2(2):16–19.
    1. Johnson E., Lanier W., Merrill R., Crook J., Porucznik C., Rolfs R., Sauer B. Unintentional prescription opioid-related overdose deaths: Description of decedents by next of kin or best contact, Utah, 2008–2009. Journal of General Internal Medicine. 2013;28(4):522–529.
    1. Joudrey P.J., Khan M.R., Wang E.A., Scheidell J.D., Jennifer Edelman E., Keith Mcinnes D., Fox A.D. A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice. 2019;14(1):1–14.
    1. Karamouzian M., Dohoo C., Forsting S., Mcneil R., Kerr T., Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduction Journal. 2018;15(1):1–8.
    1. Kroenke K., Spitzer R.L. The PHQ-9: A new depression diagnostic and severity measure. Psychiatric Annals. 2002;32:509–515.
    1. Larance B., Bruno R., Lintzeris N., Degenhardt L., Black E., Brown A.…Mattick R.P. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The opioid-related behaviours in treatment (ORBIT) scale. Drug and Alcohol Dependence. 2016;159:42–52.
    1. Lewis C.R., Vo H.T., Fishman M. Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: A review. Substance Abuse and Rehabilitation. 2017;8:79–95.
    1. McCarthy M. Suicide rates rise sharply in the US, figures show. British Medical Journal. 2016;353(2355)
    1. McDonald R., Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177–1187.
    1. Morgan J., Jones A.L. The role of naloxone in the opioid crisis. Toxicology Communications. 2018;2(1):15–18.
    1. National Academies of Sciences, Engineering, and Medicine . The National Academies Press; Washington, DC: 2019. Medications for opioid use disorder save lives.
    1. Oquendo M.A., Volkow N.D. Suicide: A silent contributor to opioid-overdose deaths. The New England Journal of Medicine. 2018;378(17):1567–1569.
    1. Porucznik C.A., Johnson E.M., Sauer B., Crook J., Rolfs R.T. Studying adverse events related to prescription opioids: The Utah experience. Pain Medicine. 2011;12:S16–S25.
    1. Pouget E.R., Bennett A.S., Elliott L., Wolfson-Stofko B., Almeñana R., Britton P.C., Rosenblum A. Development of an opioid-related overdose risk behavior scale (ORBS) Substance Abuse. 2017;38(3):239–244.
    1. Rando J., Broering D., Olson J.E., Marco C., Evans S.B. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. American Journal of Emergency Medicine. 2015;33(9):1201–1204.
    1. Richardson L.P., Russo J.E., Katon W., Mccarty C.A., Devries A., Edlund M.J.…Sullivan M. Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. Journal of Adolescent Health. 2012;50(6):553–558.
    1. Rudd R.A., Aleshire N., Zibbell J., Gladden R. Increases in drug and opioid overdose deaths--United States, 2000–2014. MMWR. Morbidity and Mortality Weekly Report. 2016;64(50–51):1378–1382.
    1. Rudd R.A., Seth P., David F., Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR: Morbidity and Mortality Weekly Report. 2016;65(5051):1445–1452.
    1. Saitz R., Cheng D.M., Winter M., Kim T.W., Meli S.M., Allensworth-Davies D.…Samet J.H. Chronic care management for dependence on alcohol and other drugs: The AHEAD randomized trial. JAMA. 2013;310(11):1156–1167.
    1. Seal K.H., Kral A.H., Gee L., Moore L.D., Bluthenthal R.N., Lorvick J., Edlin B.R. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco bay area, 1998–1999. American Journal of Public Health. 2001;91(11):1842–1846.
    1. Seal K.H., Shi Y., Cohen G., Cohen B.E., Maguen S., Krebs E.E., Neylan T.C. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947.
    1. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E.…Dunbar G.C. The Mini-International (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998;59:22–57. Suppl 20.
    1. Tobin K., Latkin C. The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. Journal of Urban Health. 2003;80(2):220–229.
    1. Walley A.Y., Xuan Z., Hackman H.H., Quinn E., Doe-Simkins M., Sorensen-Alawad A.…Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. British Medical Journal. 2013;346(7894)
    1. Wheeler E., Davidson P.J., Jones T.S., Irwin K.S. Community-based opioid overdose prevention programs providing naloxone — United States, 2010. Morbidity and Mortality Weekly Report. 2012;61(6):101–105.
    1. Wines J.D., Saitz R., Horton N.J., Lloyd-Travaglini C., Samet J.H. Overdose after detoxification: A prospective study. Drug and Alcohol Dependence. 2007;89(2):161–169.
    1. Yokell M.A., Delgado M.K., Zaller N.D., Wang N.E., McGowan S.K., Green T.C. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Internal Medicine. 2014;174(12):2034–2037.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera